Richard Hoyt
Förmögenhet: 15 759 $ per 2026-05-31
Förmögenhet: 15 759 $ per 2026-05-31
Mr. Richard Hoyt is a Chairman at ZYUS Life Sciences Corp., a Vice President-Business Development at Xeris Biopharma Holdings, Inc., a Chairman at ZYUS Life Sciences, Inc. and a Managing Partner at Ozark Transaction Advisors LLC.
Mr. Hoyt was previously employed as an Independent Director by CanniMed Therapeutics, Inc., a Vice President-Business Development & Licensing by Mallinckrodt Plc, and a Vice President-Business Development by Xeris Pharmaceuticals, Inc. He also served on the board at Biotechnology Research & Development Corp.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-11-26 | 309 002 ( 0,39 % ) | 15 759 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| ZYUS LIFE SCIENCES CORPORATION | Ordförande | 2020-09-01 |
| XERIS BIOPHARMA HOLDINGS, INC. | Företagsledare/Principal | 2019-11-01 |
ZYUS Life Sciences, Inc.
ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical manufacturing company | Ordförande | - |
Ozark Transaction Advisors LLC | Företagsledare/Principal | - |
| Företag | Position | Slut |
|---|---|---|
| MALLINCKRODT PLC | Företagsledare/Principal | 2018-09-01 |
| CANNIMED THERAPEUTICS INC | Direktör/Styrelseledamot | 2018-03-15 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Företagsledare/Principal | - |
Biotechnology Research & Development Corp.
Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Provides research on animal and plant healthcare, material sciences and biotechnology | Direktör/Styrelseledamot | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 8 |
|---|---|
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Health Technology |
Keenova Therapeutics Plc
Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
Biotechnology Research & Development Corp.
Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Provides research on animal and plant healthcare, material sciences and biotechnology | Commercial Services |
CanniMed Therapeutics, Inc.
CanniMed Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in production of pharmaceutical grade cannabis products | Health Technology |
ZYUS Life Sciences, Inc.
ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical manufacturing company | Health Technology |
Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc. BiotechnologyHealth Technology Develops and commercializes therapies | Health Technology |
ZYUS Life Sciences Corp.
ZYUS Life Sciences Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes cannabinoid-based pharmaceutical drug product candidates and therapeutics | Health Technology |
Ozark Transaction Advisors LLC |
Välj din utgåva
All finansiell information anpassad till den nationella nivån